Dacomitinib is a medication that belongs to a class of drugs known as tyrosine kinase inhibitors. It is primarily used in the treatment of non-small cell lung cancer that has spread to other parts of the body. Dacomitinib works by blocking the action of certain proteins that are involved in the growth and spread of cancer cells.

As a medical professional, it is important to inform patients about the potential side effects of dacomitinib. Common side effects may include diarrhea, skin rash, mouth sores, and decreased appetite. It is important for patients to report any side effects to their healthcare provider so that they can be properly managed.

It is also important to discuss with patients the importance of taking dacomitinib exactly as prescribed. Missing doses or stopping the medication without consulting a healthcare provider can reduce its effectiveness in treating cancer.

Patients should also be aware of the potential drug interactions that can occur with dacomitinib. It is important to inform healthcare providers of all medications, supplements, and herbal products that are being taken to avoid any potential interactions.

Overall, dacomitinib can be an effective treatment option for patients with non-small cell lung cancer. As a medical professional, it is important to provide patients with the information they need to make informed decisions about their treatment and to support them throughout their cancer journey.